University of Pennsylvania Medical Center Guidelines for Antibiotic Use
| Clinical Setting | Empiric Treatment | Likely Pathogens | Definitive Treatment | Dosage Regimen | Duration |
| Malignant Otitis Externa1 | |||||
| Mild/moderate | levofloxacin | P. aeruginosa | same as empiric | 500mg PO q 24 hour | 2-6 weeks |
| Severe | piperacillin + gentamicin | P. aeruginosa |
same as empiric (switch to levofloxacin when clinically indicated) |
piperacillin 4 gm q 6 hour gentamicin - see this link |
|
| Acute Sinusitis | |||||
|
Mild Mod/severe (temp., facial pain,TMP/SMX failure) |
TMP/SMX amoxicillin/ clavulanic acid2 |
S. pneumoniae | amoxicillin3 | 875 mg PO bid | 10 days |
| H. influenzae | TMP/SMX | 160/800mg (1 double strength tablet) PO BID | |||
| M. catarrhalis | |||||
| oral anaerobes | |||||
| Tonsillitis/ Pharyngitis | |||||
| Mild | penicillin V4 | group A streptococcus | penicillin V | 250mg PO q 6 hour -10 days |
|
| Moderate5 | benzathine penicillin G4 IM x 1 or penicillin V | same as above |
benzathine penicillin G or penicillin V |
1.2mu IM x 1 dose once or 250mg PO q 6 hour -10 days |
|
| Severe (abscess6 or treatment failure) | ampicillin/sulbactam |
group A streptococcus H. influenzae S. aureus oral anaerobes |
ampicillin/sulbactam |
1.5gm IV q 6 hour |
10-14 days6 |
1Surgical debridement may be indicated
2Amoxicillin/clavulanic acid dose: 875 mg PO BID x 10 days
3Review susceptibilities-S. pneumoniae resistance is about 15 to 25 %
4If penicillin allergy is rash then cephalexin 250 mg po qid; if allergy severe (urticaria, angioedema, or anaphylaxis) then eyrthromycin 250 mg po qid (check susceptibility - resistance rate 5-10%)
5 If multiple or recurrent episodes, consider clindamycin 150 mg po qid (check suscept - 5-10% resistance), amoxicillin/clavulanic acid 500 mg po bid or benzathine penicillin 1.2 mu IM once. Rifampin can be added to eradicate streptococci from the pharynx (600 mg po qd x 4 d)
6Abscess should be drained
updated 4/1/2003 by Lori LaRosa